Abstract:The development of near-infrared (NIR) laser triggered phototheranostics for multimodal imaging-guided combination therapy is highly desirable. However, multiple laser sources, as well as inadequate therapeutic efficacy, impede the application of phototheranostics. Here, we develop an all-in-one theranostic nanoagent PEGylated x NPs (DCDMs) with a flower-like structure fabricated by coating uniformly sized down-conversion nanoparticles (DCNPs) with dendritic mesoporous silica (DMSN) and then loading the ultrasmall oxygen-deficient molybdenum oxide nanoparticles (MoOx NPs) inside through an electrostatic interaction. Owing to the doping of Nd ions, when excited by an 808 nm laser, DCNPs emit bright NIR-II emissions (1060 and 1300 nm), which have characteristic high spatial resolution and deep tissue penetration. In terms of treatment, MoOx NPs could be specifically activated by excessive hydrogen peroxide (H2O2) in the tumor microenvironment, thus generating 1O2via the Russell mechanism. In addition, the excessive glutathione (GSH) in the tumor cells could be depleted through the Mo-mediated redox reaction, thus effectively decreasing the antioxidant capacity of tumor cells. Importantly, the excellent photothermal properties (photothermal conversion efficiency of 51.5% under an 808 nm laser) synergistically accelerate the generation of 1O2. This cyclic redox reaction of molybdenum indeed ensured the high efficacy of tumor-specific therapy, leaving the normal tissues unharmed. MoOx NPs could also efficiently catalyze tumor endogenous H2O2 into a considerable amount of O2 in an acidic tumor microenvironment, thus relieving hypoxia in tumor tissues. Moreover, the computed tomography (CT) and T1-weighted magnetic resonance imaging (MRI) effect from Gd3+ and Y3+ ions make DCNPs act as a hybrid imaging agent, allowing comprehensive analysis of tumor lesions. Both in vitro and in vivo experiments validate that such an "all-in-one" nanoplatform possesses desirable anticancer abilities under single laser source irradiation, benefiting from the NIR-II fluorescence/CT/MR multimodal imaging-guided photothermal/chemodynamic synergistic therapy. Overall, our strategy paves the way to explore other noninvasive cancer phototheranostics.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c17923?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c17923</a>.Experimental methods, HRTEM images, XRD patterns, N2 adsorption–desorption isotherms, pore size distribution, extinction coefficient, photostability and colloidal stability, ESR spectra, schematic illustration of the Russell mechanism, oxygen generation, cell viability, line profiles of CT and MRI values, photothermal behavior under a 1064 nm laser, digital photo of tumors harvested from different groups, H&E stained photographs of major organs, and TEM images of DCDMs after biodegradation (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c17923/suppl_file/am0c17923_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

A NanoFlare-Based Strategy for in Situ Tumor Margin Demarcation and Neoadjuvant Gene/Photothermal Therapy.

Intracellular Fluorescent Light-Up Bioprobes with Different Morphology for Image-Guided Photothermal Cancer Therapy

Nir-Activated Spatiotemporally Controllable Nanoagent For Achieving Synergistic Gene-Chemo-Photothermal Therapy In Tumor Ablation

Intraoperative Assessment and Photothermal Ablation of the Tumor Margins Using Gold Nanoparticles

Target-Induced Core-Satellite Nanostructure Assembly Strategy for Dual-Signal-On Fluorescence Imaging and Raman Quantification of Intracellular MicroRNA Guided Photothermal Therapy

One Stone, Three Birds: Multifunctional Nanodots As “pilot Light” for Guiding Surgery, Enhanced Radiotherapy, and Brachytherapy of Tumors

Activatable Nanoprobe with Aggregation-Induced Dual Fluorescence and Photoacoustic Signal Enhancement for Tumor Precision Imaging and Radiotherapy.

A Spatiotemporally Controlled Gene‐Regulation Strategy for Combined Tumor Therapy Based on Upconversion Hybrid Nanosystem

In Situ Nanozyme-Amplified NIR-II Phototheranostics for Tumor-Specific Imaging and Therapy

An Activatable Phototheranostic Nanoplatform for Tumor Specific NIR-II Fluorescence Imaging and Synergistic NIR-II Photothermal-Chemodynamic Therapy.

Flower-Like Nanosensors for Photoacoustic-Enhanced Lysosomal Escape and Cytoplasmic Marker-Activated Fluorescence: Enabling High-Contrast Identification and Photothermal Ablation of Minimal Residual Disease in Breast Cancer.

Gold Nanorods Electrostatically Binding Nucleic Acid Probe for In Vivo MicroRNA Amplified Detection and Photoacoustic Imaging-Guided Photothermal Therapy

DNA-enabled rational design of fluorescence-Raman bimodal nanoprobes for cancer imaging and therapy

Multimode Imaging-Guided Photothermal/Chemodynamic Synergistic Therapy Nanoagent with a Tumor Microenvironment Responded Effect

Gold Nanoprisms As a Hybrid in Vivo Cancer Theranostic Platform for in Situ Photoacoustic Imaging, Angiography, and Localized Hyperthermia

NIR-IIb Fluorescence-Image Guided Synergistic Surgery/ Starvation/chemodynamic Therapy: an Innovative Treatment Paradigm for Malignant Non-Small Cell Lung Cancers

Design of Light/ROS Cascade-Responsive Tumor-Recognizing Nanotheranostics for Spatiotemporally Controlled Drug Release in Locoregional Photo-Chemotherapy.

Excitation-Selectable Nanoprobe for Tumor Fluorescence Imaging and Near-Infrared Thermal Therapy.

On-demand Reprogramming of Immunosuppressive Microenvironment in Tumor Tissue Via Multi-Regulation of Carcinogenic Micrornas and RNAs Dependent Photothermal-Immunotherapy Using Engineered Gold Nanoparticles for Malignant Tumor Treatment

Single‐Photomolecular Nanotheranostics for Synergetic Near‐Infrared Fluorescence and Photoacoustic Imaging‐Guided Highly Effective Photothermal Ablation

Near-infrared Fluorescence Imaging of Cancer Cells and Tumors Through Specific Biosynthesis of Silver Nanoclusters